1,8,15,22-Tetrazacyclooctacosane-2,7,16,21-tetraone

CAS : 4238-35-1

Ref. 3D-EAA23835

Informations sur le produit

• Nom: 1,8,15,22-Tetrazacyclooctacosane-2,7,16,21-tetraone

Description

1,8,15,22-Tetrazacyclooctacosane-2,7,16,21-tetraone is an inhibitor with potent anticancer properties. It induces apoptosis in cancer cells by inhibiting kinases that are critical for cell survival and proliferation. This compound has been shown to be effective against various types of cancer in both Chinese hamster ovary and human cancer cell lines. Additionally, it has been found to increase the excretion of the anti-allergic drug rupatadine in urine. The use of 1,8,15,22-Tetrazacyclooctacosane-2,7,16,21-tetraone as a tumor inhibitor has also been investigated in combination with other kinase inhibitors such as bendamustine analogs. This compound holds great potential for the development of new anticancer therapies.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 452.6 g/mol
• Formule: C₂₄H₄₄N₄O₄
• Degré de pureté: Min. 95%